Molbio Diagnostics Limited (NSE:MOLBIO)
India flag India · Delayed Price · Currency is INR
1,320.10
-15.90 (-1.19%)
Nov 11, 2026, 1:00 PM IST

Molbio Diagnostics Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
14,33114,45710,2048,3663,325
Revenue Growth
40.44%41.68%21.98%151.63%-
Gross Profit
8,5498,5895,9704,9051,847
Operating Income
2,4432,6702,2311,942136.37
Net Income
1,5441,6661,4511,020-7.26
Earnings Per Share
13.6514.7712.879.04-0.06
EPS Growth
6.04%14.76%42.37%--

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '25 Mar '24 Mar '23
India
13,0668,2337,5432,838
outside India
1,3901,971822.48487.1
Total
14,45710,2048,3663,325

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
5,6933,7061,291222.1972.39
Total Debt
3,8984,5011,4691,8361,185
Net Cash (Debt)
1,794-794.59-178.78-1,614-1,113
Net Cash Growth
-----
Net Cash Per Share
15.87-7.05-1.59-14.31-9.89

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
4,568503.852,87195.7641.32
Capital Expenditures
-610.61-500.22-546.61-263.68-144.98
Free Cash Flow
3,9573.632,324-167.98496.34
Free Cash Flow Growth
70.24%-99.84%---

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
59.65%59.41%58.51%58.63%55.55%
Operating Margin
17.05%18.47%21.87%23.21%4.10%
Pretax Margin
14.52%15.99%19.05%15.50%2.87%
Profit Margin
10.77%11.52%14.22%12.19%-0.22%
FCF Margin
27.61%0.03%22.78%-2.01%14.93%